Barclays Debuts ‘Series B’ iPath ETNs

Barclays Debuts ‘Series B’ iPath ETNs

New products replace existing ones that are delisting or maturing.
Reviewed by: Staff
Edited by: Staff

Today Barclays rolled out 17 ETNs designed to replace existing products that are either maturing or delisting, part of an extensive revamp of the company’s iPath family of ETNs.

The new products include 15 new commodity ETNs that replace corresponding first-generation products Barclays will be delisting:

The new commodity ETNs cost just 0.45%, whereas the originals carried expense ratios of 0.75%. The fees are also charged differently, in a more consistent and predictable manner similar to how ETFs charge their fees. The new products are also callable, meaning Barclays can redeem them from investors.

Another two of the ETNs launching today replace other iPath products set to mature in January 2019. These ETNs carry the same price, however. Unlike their predecessors, the new VIX ETNs list on the Cboe exchange rather than the NYSE Arca. Cboe Global Markets is the parent company of

The old ETNs are the iPath S&P 500 VIX Short-Term Futures ETN (VXX) and the iPath S&P 500 VIX Mid-Term Futures ETN (VXZ), while the new ones replacing them are as follows:

Contact Heather Bell at [email protected] is the single source for ETF intelligence. We provide real-time ETF news and analysis to educate investors and drive financial knowledge in the space. Our personalized and accurate information, alongside industry-leading financial tools, are depended upon to develop winning investment and financial decisions. At, we strive to serve both the individual investor as well as the professional financial advisor to educate and grow the ETF community.